| Anuh Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506260 |
NSE Symbol : ANUHPHR |
P/E(TTM) : 18.60 |
|
ISIN Demat : INE489G01022 |
Div & Yield% : 1.83 |
EPS(TTM) : 4.41 |
|
Book Value(₹) : 35.14 |
Market Cap(₹Cr) : 821.94 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 193.81 | 202.12 | 197.18 | 185.88 | 186.48 | 198.14 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 193.81 | 202.12 | 197.18 | 185.88 | 186.48 | 198.14 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.08 | -1.25 | 1.79 | 0.98 | 3.39 | 1.40 |
| Total Income | 196.89 | 200.86 | 198.97 | 186.86 | 189.87 | 199.54 |
| Total Expenditure | 177.52 | 182.23 | 178.06 | 174.00 | 176.19 | 179.47 |
| PBIDT | 19.36 | 18.63 | 20.91 | 12.86 | 13.68 | 20.07 |
| Interest | 0.00 | 0.11 | 0.08 | 0.08 | 0.21 | 0.03 |
| PBDT | 19.36 | 18.52 | 20.83 | 12.78 | 13.47 | 20.04 |
| Depreciation | 2.43 | 3.00 | 3.00 | 2.86 | 2.52 | 2.76 |
| Tax | 4.13 | 4.76 | 4.97 | 2.80 | 2.49 | 5.42 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.37 | -0.92 | -0.60 | -0.49 | 0.16 | -0.59 |
| Reported Profit After Tax | 11.42 | 11.68 | 13.45 | 7.61 | 8.30 | 12.46 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 11.42 | 11.68 | 13.45 | 7.61 | 8.30 | 12.46 |
| EPS (Unit Curr.) | 1.14 | 1.17 | 1.34 | 0.76 | 1.66 | 2.49 |
| EPS (Adj) (Unit Curr.) | 1.14 | 1.17 | 1.34 | 0.76 | 0.83 | 1.25 |
| Calculated EPS (Unit Curr.) | 1.14 | 1.17 | 1.34 | 0.76 | 1.66 | 2.49 |
| Calculated EPS (Adj) (Unit Curr.) | 1.14 | 1.17 | 1.34 | 0.76 | 0.83 | 1.25 |
| Calculated EPS (Ann.) (Unit Curr.) | 4.56 | 4.66 | 5.37 | 3.04 | 6.63 | 9.94 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 4.56 | 4.66 | 5.37 | 3.04 | 3.32 | 4.97 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 50.11 | 50.11 | 50.11 | 50.11 | 25.06 | 25.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.99 | 9.22 | 10.60 | 6.92 | 7.34 | 10.13 |
| PBDTM(%) | 9.99 | 9.16 | 10.56 | 6.88 | 7.22 | 10.11 |
| PATM(%) | 5.89 | 5.78 | 6.82 | 4.09 | 4.45 | 6.29 |
